Theranos Intarcia Moderna - Three Unicorns of the Apocalypse

Discussion in 'Biotech Startups' started by Milly Vanilly, Jul 7, 2017 at 5:35 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    tech is as good as the FDA approvals - count them up !!
     

  2. anonymous

    anonymous Guest

    Yeah, without good leadership it could end up like the others. The company is good as its people gets. If the wheels of change begin with the board and executive senior directors, like some posted on this board previously, then it could move forward. Some of them are getting overpaid and getting away with their well heeled connections within the company. It's suspicious to see that some are too young and are well positioned and will probably leave eventually and go to another company just so long they can ride the ship and make believe they know what they're doing. Just take a look at External manufacturing dept....
     
  3. anonymous

    anonymous Guest

    Moderna is overhyped like the other startups. They don't have good management, what they have are good salespeople selling their unicorn vision.
     
  4. anonymous

    anonymous Guest

    I actually completely disagree- the tech is solid, and they’re in the middle of getting their stuff together, management- wise
     
  5. anonymous

    anonymous Guest

    MODENRON, fact, period - A whole bunch of billions in market cap covering a mountain of worthless shit

    10 years and nothing published, nothing reviewed, and nothing to show for the wasted billions
     
  6. anonymous

    anonymous Guest

    What do all you genius Moderna haters have to say now? All of a sudden the “next Enron” has the single most effective vaccine to finally end this worldwide pandemic. They literally are saving millions of people from the scourge that shutdown the world and killed millions. High risk and ultimately high reward.

    Admit you were wrong. You are probably one of the billions of people scouring the web to get a vaccine appointment right now.